We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+13.84%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.52B
AUM Growth
+$673M
Cap. Flow
-$326M
Cap. Flow %
-3.42%
Top 10 Hldgs %
9.28%
Holding
1,001
New
72
Increased
350
Reduced
347
Closed
95

Top Buys

Rank Stock Value
1
HELE icon
Helen of Troy
HELE
+$26.1M
2
ROG icon
Rogers Corp
ROG
+$16.2M
3
CLB icon
Core Laboratories
CLB
+$14.3M
4
HLIT icon
Harmonic Inc
HLIT
+$13.5M
5
MOV icon
Movado Group
MOV
+$13M

Sector Composition

Rank Sector Weight
1 Industrials 27.63%
2 Technology 17.45%
3 Financials 12.95%
4 Consumer Discretionary 12.77%
5 Materials 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWE
676
DELISTED
World Wrestling Entertainment
WWE
$1.65M 0.02%
24,084
-2,487
-9% -$188K
PYCR
677
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$1.65M 0.02%
+67,320
New +$1.86M
CHMG icon
678
Chemung Financial Corp
CHMG
$394M
$1.65M 0.02%
35,905
-26,818
-43% -$1.2M
EZPW icon
679
Ezcorp Inc
EZPW
$1.79B
$1.64M 0.02%
201,000
BIOX icon
680
Bioceres Crop Solutions
BIOX
$20.6M
$1.6M 0.02%
133,000
+20,000
+18% +$260K
IBP icon
681
Installed Building Products
IBP
$6.21B
$1.58M 0.02%
18,506
+5,640
+44% +$475K
SSYS icon
682
Stratasys
SSYS
$666M
$1.58M 0.02%
133,000
EGIO
683
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.58M 0.02%
34,857
+5,202
+18% +$401K
ONTF
684
DELISTED
ON24
ONTF
$1.57M 0.02%
182,000
-250,000
-58% -$2M
SUPN icon
685
Supernus Pharmaceuticals
SUPN
$2.7B
$1.56M 0.02%
43,803
-932
-2% -$32.4K
IDCC icon
686
InterDigital
IDCC
$6.75B
$1.56M 0.02%
31,483
+10,234
+48% +$499K
EXTR icon
687
Extreme Networks
EXTR
$3.8B
$1.56M 0.02%
85,012
-1,178
-1% -$20.6K
KMX icon
688
CarMax
KMX
$8.39B
$1.52M 0.02%
24,975
MHH icon
689
Mastech Digital
MHH
$95.4M
$1.52M 0.02%
138,106
+6,451
+5% +$89.6K
PDCO
690
DELISTED
Patterson Companies, Inc.
PDCO
$1.52M 0.02%
54,244
+35
+0.1% +$966
PCTY icon
691
Paylocity
PCTY
$7.75B
$1.51M 0.02%
7,786
LOB icon
692
Live Oak Bancshares
LOB
$1.98B
$1.5M 0.02%
49,745
+7,900
+19% +$252K
VALU icon
693
Value Line
VALU
$333M
$1.5M 0.02%
29,470
-3,362
-10% -$190K
LPTH icon
694
Lightpath Technologies
LPTH
$590M
$1.49M 0.02%
1,225,036
WSFS icon
695
WSFS Financial
WSFS
$4.14B
$1.48M 0.02%
32,552
-9,452
-23% -$444K
MXCT icon
696
MaxCyte
MXCT
$108M
$1.47M 0.02%
270,125
+48,800
+22% +$299K
VIR icon
697
Vir Biotechnology
VIR
$1.46B
$1.44M 0.02%
56,903
+28,595
+101% +$701K
ASIX icon
698
AdvanSix
ASIX
$542M
$1.44M 0.02%
37,797
+6,891
+22% +$258K
KKR icon
699
KKR & Co
KKR
$89.1B
$1.43M 0.02%
30,858
AWR icon
700
American States Water
AWR
$3.44B
$1.41M 0.01%
15,221
+5,002
+49% +$456K

Similar funds

Royce & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Royce & Associates held 1,001 positions worth $9.52B, up 7.6% from $8.84B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Royce & Associates withdrew a net $326M in Q4 2022, closing 95 positions and reducing 347 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $58.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Rogers Corp worth $12.4M.

  • Royce & Associates's largest Q4 2022 buy was Rogers Corp: 104,264 shares worth $12.4M.
  • Royce & Associates added most to Helen of Troy in Q4 2022, an estimated $26.1M increase.
  • Royce & Associates's biggest Q4 2022 reduction was Kulicke & Soffa, cutting an estimated $39.9M.
  • Royce & Associates fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $58.3M.
  • Royce & Associates's ten largest holdings make up 9.3% of its $9.52B portfolio in Q4 2022.
  • Royce & Associates opened 72 new positions and closed 95 in Q4 2022.
  • Royce & Associates's portfolio value rose 7.6% quarter-over-quarter to $9.52B.

Based on Royce & Associates's 13F filing for Q4 2022, filed 13 Feb 2023.